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Background: Segregational stability of plasmids is of major concern for recombinant bacterial production strains.
One of the best strategies to counteract plasmid loss is the use of auxotrophic mutants which are complemented
with the lacking gene along with the product-relevant ones. However, these knockout mutants often show
unwanted growth in complex standard media or no growth at all under uncomplemented conditions. This led to
the choice of a gene for knockout that only connects two essential arms of an essential metabolic pathway – the
glycolysis.
Results: Triosephosphate isomerase was chosen because its knockout will have a tremendous effect on growth on
glucose as well as on glycerol. On glycerol the effect is almost absolute whereas on glucose growth is still possible,
but with considerably lower rate than usual. This feature is essential because it may render cloning easier. This
enzymatic activity was successfully tested as an alternative to antibiotic-based plasmid selection. Expression of a
model recombinant β-glucanase in continuous cultivation was possible with stable maintenance of the plasmid.
In addition, the complementation of tpiA knockout strains by the corresponding plasmids and their growth
characteristics were tested on a series of complex and synthetic media. The accumulation of methylglyoxal during
the growth of tpiA-deficient strains was shown to be a possible cause for the growth disadvantage of these strains
in comparison to the parent strain for the Keio Collection strain or the complemented knock-out strain.
Conclusion: Through the use of this new auxotrophic complementation system, antibiotic-free cloning and
selection of recombinant plasmid were possible. Continuous cultivation and recombinant protein expression with
high segregational stability over an extended time period was also demonstrated.
Keywords: Plasmid, Segregational stability, Triosephosphate isomerase, Auxotrophy, Methylglyoxal, Keio collection,
Knockout strain, Continuous cultivation, tpiABackground
In 2009 almost one third (45 out of 151) of commercial
biopharmaceutical recombinant proteins licensed by FDA
and EMEA were produced by cultivation of Escherichia coli
[1]. This meant that nearly 30% of high-value recombinant
proteins were produced by means of a plasmid-based
expression system. Various other commercial recombinant
proteins (e.g. enzymes) or non-protein products (e.g.
amino acids) were also obtained with strains of E. coli
harboring plasmids. Searching the Science Citation Index* Correspondence: karl.friehs@uni-bielefeld.de
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article, unless otherwise stated.database for “coli recombinant protein” would lead to
more than 26,000 results. These facts show the high im-
portance of E. coli as an expression system for commercial
as well as scientific use.
Expression systems based on E. coli depend in almost
all cases on the presence of at least one plasmid, which
has to be segregated into dividing cells during growth.
Insufficient segregational plasmid stability would render
plasmid-based expression systems useless. Therefore, a var-
iety of methods have been developed in order to achieve
plasmid stability [2]. The commonly used method consists
in adding antibiotics into the cultivation medium and
placing genes for antibiotic resistance on the plasmid
carrying the target gene. This strategy is widely used inCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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to be applied. In industrial biotechnology, the addition of
antibiotics can be generally excluded – not only with re-
spect to economic reasons. The elimination of antibiotics
from media and waste streams maybe required during
downstream processing. Therefore, other methods for
plasmid stabilization are in high demand.
A simple strategy in trying to keep a high segregational
plasmid stability without adding antibiotics consists in
using plasmids of high copy number and expecting that
the statistical distribution of plasmids during cell div-
ision may always yield cells with at least some plasmids.
This works fine as long as the average plasmid copy
number is homogeneous [3]. As soon as cells with very
low plasmid copy numbers show up preferentially during
high growth rates, cells might have not enough time to
synthesize plasmids in high copy numbers. Caused by
the additional metabolic burden, plasmids may be lost
completely, since plasmid-free cells would gain a growth
advantage in comparison to plasmid-bearing cells. This
would have a drastic influence especially on fed-batch-
and continuous cultivation processes.
High metabolic burden, basal transcription levels and
possible toxic effects of recombinant proteins ask for
other methods for stabilizing plasmids. In some cases,
changes in the cultivation strategies, mainly by decreas-
ing the specific growth rate, may lead to sufficient
plasmid stability. This can be achieved by reducing the
cultivation temperature or changing the carbon source
of the medium. However, most methods are based on
adding some stabilizing elements by genetic engineering.
Some lessons may be learned from nature’s strategies
to ensure plasmid segregation. Thus, single copy plas-
mids often show sophisticated stabilizing mechanisms
like that based on the par-system which leads to a
controlled distribution of plasmids, similar to the highly
organized and controlled chromosome distribution in
higher organisms. The par-system consists of at least two
protein-coding genes and one special site on the plasmid
for controlled distribution in the dividing cell [4].
Other systems lead to the post-segregational killing of
plasmid-free cells and need the genetic information of a
toxin and its corresponding antidote, with the antidote
on the target plasmid [5]. Such a combination was
recently applied for the development of a Streptomyces
based protein expression system [6].
In all these cases, the plasmids may become quite
large, leading to a higher metabolic burden. A larger size
may also lead to another problem - decreased structural
plasmid stability due to stochastic mutations, which
would lead to a reduction in productivity, as well. In this
regard, the ccdB/ccdA poison-antidote system, modified
as a separate-component-stabilization system provides
an alternative using very small genetic constructs toprovide efficient antibiotic-free maintenance of plasmid
in E. coli [7].
Many studies on DNA vaccine production have par-
ticularly been interested in alternative plasmid selection
mechanisms, due to the need to avoid all kinds of resist-
ance genes or proteins in therapeutic DNA according to
safety standards. An RNA based method, using constitu-
tive expression of sacB as a counter-selectable marker
during growth on sucrose was reported to be able to
bring about antibiotic-free selection and highly pro-
ductive fermentation while not being restricted to ColE1
vectors [8].
Another perhaps more elegant way to stabilize the
propagation of plasmids, is to destroy the function of an
essential gene on the chromosome and place this gene
on the plasmid carrying the target genes. This approach
requires a strategy to generate competent cells of the
now auxotrophic strain. One of the first methods for
commercial use was the valS-system [9]. The wild-type
gene for valyl-tRNA synthetase (valS) of the host carries
a temperature-sensitive mutation, whereas the gene
without mutation is placed on a plasmid. For transform-
ation the host is grown at 30°C. During cultivations at
37°C the mutated synthetase on the chromosome loses
its function and only cells carrying the valS-harboring
plasmid can survive and grow. However, the valS gene is
still around on the chromosome and the selection pres-
sure favors a recombination of the mutated valS on the
chromosome and the wild type valS on the plasmid.
Such a recombination produces revertants with no selec-
tion pressure by valS and leads to plasmid instability.
One way to reduce the probability of recombination is
the complete knockout of the chromosomal gene. In the
case of valS this would not allow to obtain viable
cells for transformation and, therefore, would not be
practicable.
The Operator-Repressor-Titration (ORT) strategy is
based on negative regulation of an essential chro-
mosomal gene by an operator sequence allowing the
binding of a constitutively expressed repressor protein.
In order to allow expression of the essential gene and
survive, the cell has to titrate the repressor molecules
against a similar operator sequence that may be present
in multiple copies on the target plasmid to be maintained
[10]. The essential function complementation strategy
could also be effective at the RNA level. Recently, an
amber nonsense mutation introduced into the essential
thyA gene in the chromosome causing thymidine auxotro-
phy, was overcome by recombinant plasmids carrying a
suppressor tRNA, which allowed antibiotic-free plasmid
selection and also recombinant luciferase reporter expres-
sion in eukaryotic tissues and in tumour cells [11]. The
fabI - triclosan system, which is an essential gene- gene
product inhibitor combination, was a completely different
Figure 1 Growth testing of the wild type MG1655 and Keio
deletion mutant strains in shake-flasks on a glycerol-based
LB medium.
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associated with the biocide triclosan, the requirement of
the selection agent due to an addictive effect, the need to
induce and over-express the essential gene marker and
plasmid instability in absence of selection were also noted
[12]. Another example of antibiotic-free plasmid selection
is the strategy involving the essential infA gene coding for
translation initiation factor [13].
If an auxotrophy can be overcome by supplements in
the medium, competent cells can be prepared and trans-
formed using such a supplemented medium. This may
be achieved by knockout of an essential gene for e.g. the
synthesis of an amino acid like glycine [14]. In this case,
the glyA gene is knocked out in E. coli M15 leading to a
auxotrophic strain which can be cultivated on glycine
containing media. The glyA gene is cloned on an expres-
sion vector under the control of a constitutive weak
promoter. This system has one disadvantage in that
glycine-containing media may lead to plasmid-free cells,
and many complex industrial media contain glycine.
One solution of this problem would consist in the
construction of a knockout strain, the chromosomal
knockout of which would still allow at least some growth
on complex media. The specific growth rate for a strain
harbouring the plasmid containing the knockout gene
could generate a selection advantage high enough to keep
the plasmid in the cell population.
During the search for a gene which would be appropri-
ate for the application of the auxotrophy-based strategy
for plasmid stabilization we have focused on tpiA, the
gene for triosephosphate isomerase, a central enzyme in
the glycolysis pathway. One of recent great scientific
achievements in E. coli research was the establishment of
the so-called Keio collection of knockout strains [15].
Using the Keio tpiA knockout strain we present the con-
struction of tpiA-harbouring plasmids leading to E. coli
strains bearing plasmids of high segregational stability.
Results
Screening for an appropriate knockout gene
As a consequence of biodiesel business, glycerol has
evolved as an interesting carbon source for fermentation
processes. A closer look on the glycerol metabolism of
microorganisms, therefore, is of particular importance.
Escherichia coli can utilize glycerol as the sole carbon
and energy source. After having been imported through
the cytoplasmic membrane by a facilitator protein (GlpF),
glycerol can be metabolised on two alternative pathways
depending on the growth conditions. One consists of a
phosphorylation step by a glycerol kinase (GlpK) to yield
L-glycerol-3-phosphate followed by an oxidation step due
to the appropriate dehydrogenase (GlpD under aerobic
and GlpABC under anoxic conditions) leading to dihy-
droxyacetone phosphate (DHAP). The alternative pathwayconsists of an oxidation step by glycerol dehydrogenase
(GldA) to yield dihydroxyacetone (DHA) followed by
phosphorylation by DHA kinase (DhaK) to give DHAP as
well. The kinase-dehydrogenase (GlpK-GlpD/GlpABC)
route is the preferred one in E. coli. Accordingly, different
genes and their products come into play as there are:
glpF glpK glpD glpABC gldA and dhaK. In addition,
the resulting intermediate metabolite DHAP must be
fed into the general glycolytic pathway through iso-
merisation by triosephosphate isomerase (TpiA) as
glyceraldehyde-3-phosphate (GA3P). In the absence of
this enzyme, DHAP is converted to the toxic compound
methylglyoxal [16].
To look for an appropriate gene, four strains with a
knockout of each tpiA, glpK, gldA or glpF were grown
on LB-medium in the presence of glycerol as shown in
Figure 1.
The knockout of glpF, the gene for the glycerol uptake
facilitator protein, has no significant effect on growth.
The normal permeability of both plasma and outer
membrane may be sufficient for glycerol uptake [17].
When gldA, the glycerol dehydrogenase, is knocked out
growth on LB medium is not disturbed, either. Compared
with the growth characteristics of the E. coli MG1655 wild
type strain, these knockouts seem to be even slightly bene-
ficial. Keio strain ΔglpK, in which the glycerol kinase is
knocked out, does not grow at all, although its effect
might be partly circumvented [18]. The second strain
showing useful characteristics is that in which the trio-
sephosphate isomerase (tpiA) has been knocked out. In
consequence, this gene is considered even more appro-
priate than glpK for developing a strategy for plasmid
stabilization based on the auxotrophy principle since it
represents an enzymatic activity essential also for the gly-
colysis pathway and not only for glycerol metabolism.
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For the first construct of the tpiA gene for complemen-
tation of tpiA knockout, the wild type promoter- and
terminator sequences were chosen. Thus, chromosomal
DNA of E. coli MG1655 was isolated and the tpiA region
was amplified by PCR using 5′ · taagctggcgctatctgaatcg · 3′
and 5′ · gatggtacggcagagtgataac · 3′ as forward and reverse
primer, respectively. The amplified tpiA fragment started
150 bp upstream of the ATG start codon and ended
172 bp downstream of the TAA stop codon of the tpiA
structural gene. The upstream region started in the yiiQ
gene, coding for an unknown conserved protein, including
the predicted tpiA promoter [19]. The downstream region
reached into the cdh gene including the predicted Rho-
independent tpiA terminator [20]. The resulting PCR frag-
ment of 1090 bp length was cloned into plasmid pJET
(Fermentas) and subsequently verified by sequencing. This
construct called pJET-tpiA was transformed into the
auxotrophic host strain E. coli JW3890-2, CGSC#: 10805,
Keio Collection (ΔtpiA).
All Keio knockout strains show a special structure in
the genome. The knockout locations are found directly
behind the ATG start codon followed by the gene for
the kanamycin resistance flanked by FRT-sites. The
knockouts stop 18 bases in front of the stop codon of
the knocked out gene.
In case of the cloned fragment of the tpiA region,
there was still an overlap of 153 bp upstream and 195 bp
downstream of the structural target gene. This arrange-
ment still involved the risk that a recombination between
the knockout location on the chromosome and the tpiA
region on a plasmid could occur.
Application of the tpiA knockout in a recombinant
production system
Previous work described the extracellular production of
a hybrid bacterial β-glucanase using plasmid p582 having
a size of 6 kb and a pUC19 origin of replication [21]. A
strong constitutive synthetic promoter (CP7) controlled
the expression of the β-glucanase gene [22]. It was
followed by a Bacillus-derived signal sequence for peri-
plasmic targeting. At the carboxy terminus a hexahisti-
dine tag was placed for facilitating protein capture and
detection. The other important gene on the plasmid
p582 was kil coding for the bacteriocin release protein
of ColE1 the expression of which would initiate the
release of periplasmic proteins into the extracellular
space. This gene was under the control of the weak
stationary phase promoter of the gene fic. The plasmid
contained antibiotic resistance genes against both ampi-
cillin and kanamycin.
Using the plasmid pJET-tpiA as template, the tpiA
gene region was amplified with flanking EcoRI ends
using the primers 5′ · GGAATTCtaagctggcgctatctg · 3′and 5′ · GGAATTCgatggtacggcagagtg · 3′. This fragment
was then restricted with EcoRI and cloned into the
vector p582 at its unique EcoRI site. The result of the
cloning procedure is shown in Figure 2. The clones 1
and 4 were subsequently verified with respect to their
sequence. Partial sequencing of pFC1 and pFC4 revealed
that the regions of the cloned tpiA gene were oriented in
opposite directions.
The clones number 1 and 4, referred to hereafter as
pFC1 and pFC4 respectively, were chosen for further
studies and checked for their efficiency to complement
the TpiA auxotrophy by transforming competent cells of
the strain E. coli JW3890-2. The constructs were found
to be functional and the results from growth studies in
shake flasks with these plasmid constructs are shown in
Figure 3.
As expected, the original Keio tpiA knockout strain
(JW3890-2) did not grow in the presence of glycerol as
the only carbon source (SGA-Kan). If a complex carbon
source was present (LB-Kan), however, some growth was
observed. Only the strains complemented with plasmids
pFC1 (JW3890-2-pFC1) and pFC4 (JW3890-2-pFC4)
showed normal growth behaviour in the presence of gly-
cerol as the only carbon source (SGA-Kan). The strain
JW3890-2-pFC1 showed a shorter lag phase while the
strain with construct pFC4 had a relatively longer lag
phase. In fact, this phenomenon could be reproduced
over multiple trials. Both strains reached equal max-
imum optical densities (600 nm) of about 8.0. The media
had been supplemented with kanamycin in all three
cases. Although, both clones were able to complement
the auxotrophy of the tpiA Keio knockout strain, their
product expression capabilities differed considerably. Both
constructs were studied under batch cultivation conditions
in appropriate bioreactors.
Batch fermentation with strain JW3890-2-pFC1
Batch fermentation using the strain JW3890-2-pFC1
showed that the plasmid pFC1 could complement the
gene knockout and enable the strain to grow with glycerol
as the sole carbon source. The main results are shown in
Figure 4. A biomass concentration of about 8 g L−1 was
reached after an operating time of 24 h. Extracellular
proteins appeared delayed accumulating to 0.4 g L−1. The
extracellular concentration of β-glucanase accumulated in
parallel to the profile of total extracellular protein, but
reached a maximum volumetric activity of just 68 U mL−1.
To note again, this is the construct in which the gene tpiA
has been cloned in the forward orientation with respect to
the kil and bgl gene on the plasmid p582.
Batch fermentation with strain JW3890-2-pFC4
A similar experiment was carried out with the strain
JW3890-2-pFC4. The main results have been gathered
Figure 2 Cloning of complementation cassette into a recombinant protein expression plasmid. Above: EcoRI restriction and screening for
positive recombinant clones. Numbers 1, 4, 8, and 9 refer to clones called pFC1, pFC4, pFC8 and pFC9. V refers to the restricted vector p582 as
control. M refers to 1 kbp molecular size marker from Plasmid Factory GmbH. Below: Structure of plasmid constructs pFC1 (A) and pFC4 (B). The
constructs are each 7 kb in size and contain the recombinant β-glucanase expression gene (bgl) and the gene for the bacteriocin release protein
(kil). The origin of replication (ori) is based on pUC19. The plasmids carry the beta-lactamase gene for resistance against ampicillin and neomycin
phosphotransferase gene for resistance against kanamycin (shown as Amp R and Kan R respectively). The auxotrophy-complementing tpiA gene
along with its natural promoter (PtpiA) and terminator sequences has been cloned in the forward orientation in pFC1 and in reverse orientation
in pFC4.
Figure 3 Auxotrophy complementation of tpiA knockout strains.
Growth of tpiA knockout strain (JW3890-2) and complemented
knockout strains (JW3890-2-pFC1 and JW3890-2-pFC4) were tested in
different media based on glycerol only (SGA) or complex carbon
sources (LB) in the presence of kanamycin in shake flasks.
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this construct was able to achieve higher extracellular
recombinant enzyme activities as compared to the other
clone JW3890-2-pFC1. In fact, the maximum extra-
cellular β-glucanase activity reached 132 U mL−1 at a
somehow lower extracellular total protein concentrationFigure 4 Batch cultivation of E. coli strain JW3890-2-pFC1. The
Keio ΔtpiA knockout strain JW3890-2 complemented with the
construct pFC1 was grown in SGA medium in a 2 L in-house fermenter
with 1 L working volume at 30°C without the use of antibiotics.
Figure 5 Batch cultivation of E. coli strain JW3890-2-pFC4.
The Keio ΔtpiA knockout strain JW3890-2 complemented with the
construct pFC4 was grown in SGA medium in a 2 L in-house fermenter
with 1 L working volume at 30°C without the use of antibiotics.
Figure 6 Long-term operation of a chemostat for analysing
plasmid maintenance. Plasmid concentrations from the cells were
compared for a chemostat with the control culture E. coli JM109-
p582 and the auxotrophic system E. coli JW3890-2-pFC4 under
antibiotic-free conditions.
Figure 7 Kinetic behaviour of the expression system JW3890-2-
pFC4. The auxotrophic complementation system was analysed by
means of steady-state chemostat cultivation at different space
velocities.
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those shown in Figure 4.
Since the plasmid pFC4 showed higher extracellular
enzyme activity compared to pFC1, it was retained for
further studies.
Test of plasmid stabilization with tpiA in continuous
culture
Before starting the chemostat study, the plasmid stability
was tested in shake flasks by repeated subculture for
over 70 generations and was found to be adequate (data
not shown). As a decisive test, a chemostat was set up
consisting of a small reactor of 2 L total volume in
which a working volume of 1 L was maintained. The
SGA minimal medium based on glycerol as the only
C-source was used. The feed solution contained 20 g L−1
glycerol. No antibiotics were added to the media.
At first, the chemostat was operated for an extended
period of time for testing the plasmid stability. This test
was not only undertaken for the complemented knock-
out strain JW3890-2-pFC4, but also with the control
strain JM109-p582. In the latter case a constant space
velocity of 0.1 h−1 was maintained whereas in the former
case the space velocity was varied with a profile of
0.2 h−1 for 75 h, 0.35 h−1 for 21 h, 0.3 h−1 for 19 h,
0.1 h−1 for 77 h, 0.25 h−1 for 17 h, and 0.15 h−1 for
an additional period of 26 h. This time profile was chosen
in order to test the stability under stronger conditions
than before. The results for both experiments are gathered
in Figure 6. In the absence of antibiotics, the strain
JM109-p582 lost its plasmid continually, whereas the
plasmid concentration for the strain JW3890-2-pFC4
stabilized at about 10 ng μL-1. Thus, the strategy of com-
plementing the auxotrophy based on the triosephosphate
isomerase works even in the case of continuous operation.
As interesting as that, the expression of extracellularproteins with E. coli seemed to be feasible in continuous
operation as well.
The chemostat experiments carried out at different
space velocities offer some information about kinetic
relationships. The resulting changes in cell density, extra-
cellular β-glucanase activity, plasmid concentration and
the segregational plasmid stability were analysed and the
results obtained are shown in Figure 7. The decline of the
cell density with higher space velocities revealed a pattern
of kinetics far from exponential growth. A similar un-
favourable characteristic was found for the extracellular
enzyme activity the decline of which was rather linear as a
function of space velocity. The maximum volumetric en-
zyme productivity was fairly low at about 6.5 U mL−1 h−1.
The plasmid stability by replica plating was almost 100%
through the whole process.
Figure 8 Growth of the parent strain for the Keio Collection
BW25113 and JW3890-2 deletion mutant strains. The mutant
strains were grown in the absence or presence of the complementing
plasmid pJET-tpiA-Tart. The cultivations proceeded in shake flasks on
the glucose-based HSG medium.
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overlap
In order to decrease the possibility of recombination by
the overlaps of the chromosome base sequence and the
tpiA region on the plasmid, the original tpiA terminator
of pJET-tpiA was replaced by an artificial bidirectional
terminator leading to the plasmid pJET-tpiA-Tart. This
terminator had the sequence AAAAAAAAAAAGGGGC
GAAGCCGCCCCTTTTTTTTT and was cloned down-
stream of the tpiA gene on pJET-tpiA using the primers
shown in Table 1. The portions forming the terminator
have been shown in upper case letters.
Growth of the tpiA knockout strain on different media in
the absence or presence of the complementing plasmid
pJET-tpiA-Tart
The first step in growth analysis of the tpiA systems was
to determine the growth rates of the parent strain for
the Keio Collection E. coli BW25113, the Keio deletion
mutant JW3890-2, and the plasmid-supplemented mutant
strain. In all these experiments the tpiA deficient strain
showed lower maximal optical densities and lower growth
rates than the parent strain for the Keio Collection and
the plasmid supplemented tpiA deficient strain JW3890-2.
As an example the growth on the glucose-based HSG
medium is shown in Figure 8.
The Keio tpiA knock out strain JW3890-2 reached the
stationary phase in HSG medium early. Other media
tested were LB, LB + ampicillin, HSG + ampicillin, LB +
glycerol, LB + glucose, SGA, SGA + ampicillin, SGA + glu-
cose, SOC and TB, the terrific broth. The composition of
the media applied is to be found under Methods. As
shown in Figure 9, the tpiA knock out strain JW3890-2
showed no growth in synthetic media. In all other media
the strain showed lower growth rates than the parent
strain for the Keio Collection and the plasmid bearing
strain.
The growth rates of the parent strain for the Keio
Collection and the plasmid carrying strain were quite
similar. The plasmid supplemented strain was able to
grow in synthetic media, whereas the plasmid-free
tpiA deletion strain JW3890-2 was not able to grow
on synthetic media.
Analysis of plasmid stability
Because of the fact that the plasmid free tpiA deletion
strain could not grow on synthetic media, the experimentsTable 1 Primers for cloning an artificial terminator
behind the tpiA gene on pJET-tpiA
Primer name Sequence
tpiA Term. lacUV 5′-CGCCCCTTTTTTTTTagcctggggtgcctaatgag-3′
tpiA Term. direct 5′-GCTTCGCCCCTTTTTTTTTTTaagcctgtttagccgcttctgc-3′for antibiotic free selection were performed in SGA
medium. For this purpose shake-flask cultivations were
carried out in a repetitive fashion by reintroducing 100 μL
of a final cultivation broth into 50 mL of fresh medium in
shake flasks of 500 mL for a cultivation period of 1 day.
The same procedure was applied to the parent strain for
the Keio Collection as well as to the mutant ΔtpiA Keio
strain in the presence of either pJET-tpiA or pJET-tpiA-
Tart as complementing plasmid. For each series 13 re-
peated cultures were followed over a total period of 17 d.
For a cultivation time of 1 d, the parent strain for the
Keio Collection strain grew to an optical density of 8.1 ±
0.25 whereas the pJET-tpiA complemented mutant strain
reached 12.1 ± 0.53, and that complemented with pJET-
tpiA-Tart grew to an OD600 of 11.3 ± 0.57. The data are
given with their standard deviations collected over 10
samples. The segregational plasmid stability was tested at
the same time and was found to be stable at 98 to 100%.
In addition, the plasmid stability was tested for cultiva-
tions in the presence of different media in the absence
of ampicillin. Thus, the plasmid maintenance was found
to be absolute for the growth of the Keio mutant strain
complemented with pJET-tpiA-Tart in the case of the
media HSG, LB, LB supplemented with glucose, LB
supplemented with glycerol, SGA, SGA supplemented
with glucose, SOC as well as TB.
Because of these data it can be expected, that the TpiA
deficiency can be used as a selection marker for plasmid
stabilization.
Accumulation of methylglyoxal may lead to a toxic effect
The reason why the TpiA deficient strain stopped growing
at rather low biomass concentrations compared with
the wild type or the plasmid-supplemented strain during
Figure 9 Influence of medium composition on the growth kinetics. Maximum biomass concentration (OD600) (A) and the specific growth
rate (μ) (B) of E. coli Keio strains: BW25113, knockout mutant in the presence (JW3890-2-pJET-tpiA-Tart), and in the absence (JW3890-2) of the
complementing plasmid. The legend applies to both Figure parts (A and B).
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be a consequence of DHAP accumulating in the cells.
This could in turn lead to methylglyoxal by enzymatic
conversion of DHAP by MgsA (methylglyoxal synthase),
which should be toxic for the cells. Some experiments
were performed in order to test this assumption.
Thus, the tpiA deficient strain JW3890-2 was cultivated
in HSG medium overnight. An optical density (OD600) of
4.3 was obtained. The culture was centrifuged and the
supernatant was sterile filtered. The medium still contained10 g L−1 glycerol (initial concentration was 14.9 g L−1). In
parallel, a culture of JW3890-2-pJet-tpiA-Tart had been
cultivated in HSG medium overnight. The sterile filtered
medium was inoculated with JW3890-2-pJet-tpiA-Tart
at an initial optical density (OD600) of 0.35. The con-
centration of glycerol and methylglyoxal were analysed
in addition to the optical density along the cultivation
process. Figure 10 shows the results. The plasmid sup-
plemented strain grew to an optical density (OD600) of
20 within 8 hours by consuming 7 g L−1 glycerol.
Figure 10 Determination of the toxic effect of methylglyoxal.
Shake-flask cultivation of E. coli JW3890-2-pJet-tpiA-Tart on spent HSG
medium obtained by prior growth of JW3890-2 on HSG medium.
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the cultivation of the tpiA deficient strain and that it
was consumed during the second cultivation on the
spent medium, and fell from 1.1 mM to 0.4 mM. A
methylglyoxal concentration of 0.6 mM is assumed to be
toxic for E. coli [16]. Thus, the toxicity of methylglyoxal
generated from DHAP may force an auxotrophic effect
even in the presence of glucose as the main carbon
source.
Antibiotic free cloning
To test the possibility of antibiotic free cloning with tpiA
deficient strains, SGA agar plates were created by adding
15 g L−1 agar agar into SGA medium and pouring into
petri dishes. The tpiA deficient strain was exposed on
these plates and showed no growth. After transforming
the plasmid pJET-tpiA-Tart in a chemical competent
JW3890-2 strain, colonies appeared in the antibiotic free
SGA plates containing the correct plasmid.
Discussion
The constructs pFC1 and pFC4 contain the auxotrophy-
complementing tpiA gene in opposite orientations and
some consequences of this difference could be observed
from Figures 4 and 5. With respect to growth, it was
seen over multiple trials that the strain JW3890-2-pFC1
grew with a slightly shorter lag phase and achieved higher
maximum biomass concentrations than JW3890-2-pFC4.
Whereas, with respect to the extracellular recombinant
β-glucanase activity, the construct pFC4 clearly returned
higher volumetric activity than pFC1 and this difference
could also be reproduced over multiple trials. It is com-
mon for expression levels to vary between different clones
and in this case one possible scenario is that in the case of
pFC1, the tpiA gene could be read into the downstream
product gene bgl, which has the same orientation.
Other experiments conducted to check the secretion
achieved with these constructs showed that both theclones pFC1 and pFC4 were poor in secretion into extra-
cellular space. The analysis of samples from the stationary
phase showed that, the activities in the periplasmic frac-
tion were higher than those in the extracellular fraction.
This was in clear contrast to the control strain E. coli
JM109-p582, where the reverse was to be seen and the
equilibrium was clearly in favour of the extracellular
fraction (data not shown). In general, the control strain
showed up to 10 times the activity achieved with the
auxotrophic strains and thus represented an ideal case.
However, since the auxotrophic system offers antibiotic-
free cultivation, it deserves further development. The
question of what could be causing the suboptimal activity
of the BRP in the Keio strains remains open at this
moment. The general low efficiency of these auxotrophic
hosts could be one possible explanation. In this regard,
tpiA gene knockouts from the control strain are being
developed which should then be able to serve as efficient
hosts for the expression and secretion of the recombinant
product.
As mentioned under the section Results, the target
gene deletion in the Keio strains is restricted to the
region between the start codon and the last six codons.
The gene deletion in the control strain would be wider
and more extensive than in the Keio strain and is thus
designed to overcome the risk of recombination of the
plasmid-borne tpiA copy with the host genome and loss
of auxotrophy. Another potential route to better product-
ivity from the clones would be the expression of tpiA at
the minimum required level. This would avoid unneces-
sarily high rates of transcription and stress in the cells.
Therefore, the native P1/P2 promoters for tpiA are being
replaced with artificial weak promoters from a synthetic
promoter library [23].
Using the Keio knockout strains, a flux from DHAP
into the xylulose pathway is not possible due to the
deletion of rhamnose metabolism genes [15]. A bypass
of DHAP to lactate and pyruvate through methylglyoxal
is possible through the glyoxalase I-II pathway [24]. This
should also explain the limited growth of cells without
the complementation plasmid in complex medium. How-
ever, when glycerol is the sole carbon and energy source,
the toxicity of methylglyoxal should render this route
unfavourable. Moreover, this would only be a partial me-
tabolism and not an energy-efficient pathway to give a
growth rate advantage.
Conclusions
Antibiotic-free recombinant plasmid selection and stabili-
zation in E. coli based on the auxotrophy complementation
of the activity of TpiA has been demonstrated. From our
observations, we have been able to achieve antibiotic-
free cloning, selection, expression of a model recombin-
ant product and long-term stability of the plasmid in
Table 2 List of Escherichia coli strains used
E. coli strain Genotype Source
BW25113 (parent strain for the Keio Collection) Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), lambda−, rph-1,
Δ(rhaD-rhaB)568, hsdR514
CGSC, Yale University
JW3890-2 Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), lambda−, rph-1,
Δ(rhaD-rhaB)568, hsdR514 ΔtpiA778::kan
CGSC, Yale University
MG 1655 F−, lambda−, rph-1 DSMZ
JM109 endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, supE44,
Δ(lac-proAB), [F’ traD36, proAB, laqIqZΔM15]
Promega
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plasmid-complemented strain even under non-selective
conditions makes this system particularly attractive for
large-scale industrial processes.
Methods
The list of strains of E. coli used in this study is shown
in Table 2.
All the modifications in the knockout strain other than
the tpiA deletion are already present on the parent strain
E. coli BW25113. The modifications in the arabinose,
lactose or rhamnose metabolic genes do not have any
consequences for the current experiments reported with
this strain.
The plasmids applied for the experiments described
are gathered in Table 3.
The media applied for growth experiments with E. coli
strains are shortly explained prior to presenting their
exact composition in Tables 4 and 5 for convenience.
SGA media are fully synthetic ones. All solutions were
autoclaved separately and combined as explained in
Table 4. Depending on the preferred carbon source either
glycerol or glucose was added. For batch fermentations
with SGA, water and carbon source were autoclaved in
situ, while the other components were sterilized separately
and added to the reactor. When the medium was
complete, the pH was found to be around 6.5. This was
then corrected to a pH of 7 through addition of sterile
NaOH before inoculation. For the strain JM109, sterile-
filtered thiamine solution was added at a final concentra-
tion of 0.01 g L−1 due to its auxotrophy as given in the
genotype.
The HSG medium is a buffered complex rich medium
with glycerol as carbon source. The K2HPO4/KH2PO4Table 3 List of plasmids used
Plasmid Features/Genes
p582 rep (pUC19), bla (AmpR), npt (KanR), PCP7-bgl, Pfic-kil, T7 term
pJET 1.2 rep (pMB1), bla (AmpR), eco47IR, PlacUV5, T7 promoter, multip
pJET-tpiA rep (pMB1), bla (AmpR), eco47IR, PlacUV5, T7 promoter, residu
pFC1 rep (pUC19), bla (AmpR), npt (KanR), PCP7-bgl, Pfic-kil, T7 term
pFC4 rep (pUC19), bla (AmpR), npt (KanR), PCP7-bgl, Pfic-kil, T7 term
pJET-tpiA-Tart rep (pMB1), bla (AmpR), eco47IR, T7 promoter, residual multisolution was autoclaved separately. The pH was adjusted
to 7.4. Its composition is explained in Table 5.
Other media like LB (Lysogeny Broth), TB (Terrific
Broth) and SOC (Super Optimal broth with Catabolite
repression) were prepared according to standard labora-
tory protocols.
Cultivation
Shake flask cultivation
All cultivations were performed in a working volume of
50 mL in shake flasks of a total volume of 500 mL
equipped with baffles (Schott, Germany). The rotary shaker
LS-X (Kühner, Switzerland) had a rotating frequency of
120 min−1 and an eccentricity (diameter) of 50 mm. The
cultivation was carried out at a temperature of 30°C.
Bioreactor
The bioreactor cultivations were carried out in a 2 L in-
house fermenter with a working volume of 1 L. The
reactor had a height of 280 mm and a diameter of
94.4 mm. The impeller diameter measured 46 mm and
the impeller blades measured 12 mm on each side. A total
of 3 impellers with 6 blades each ensured good mixing for
homogeneous conditions. Moreover, the vessel contained
4 baffles with a height of 260 mm and width of 8 mm
each.
Batch cultivation
Water and glycerol for the SGA medium were sterilized
in situ along with the fermenter, while the remaining
components were sterilized separately and added under
sterile conditions. After adjusting initial pH and saturat-
ing the medium with oxygen, the fermenter was inocu-
lated from an overnight shake flask culture. AgitationSource
inator, multiple cloning site [21]
le cloning site, insertion site Fermentas
al multiple cloning site, tpiA expression cassette This work
inator, tpiA expression cassette in forward orientation This work
inator, tpiA expression cassette in reverse orientation This work
ple cloning site, tpiA expression cassette, artificial terminator This work
Table 4 Composition of the SGA medium
Solution name Volume fraction/% Component Solution concentration/g L−1 Medium concentration/g L−1
Micronutrient solution 500× 0.2 FeCl3 · 6H20 5.4 0.0108
ZnSO4 · 7H2O 1.38 0.00276
MnSO4 · H20 1.85 0.0037
CoSO4 · 7H20 0.56 0.00112
CuCl2 0.17 0.00034
H3BO3 1 0.002
Na2MoO4 · 2H2O 2.5 0.005
Citric acid hydrate 5 0.01
Salt solution 10× 10 K2HPO4 135.3 13.53
KH2PO4 66.2 6.62
Citric acid hydrate 18.4 1.84
EDTA 0.08 0.008
Glycerol solution 1 Glycerol 1,000 10
Glucose solution 10 Glucose 195.6 19.56
Ammonium sulphate solution 1.2 (NH4)2SO4 500 6
MgSO4 solution 0.24 MgSO4 250 0.6
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ation was achieved with an air space velocity of 1 vvm.
The process temperature was maintained at 37°C for the
control strain E. coli JM109-p582 and 30°C for the auxo-
trophic strains, since the latter showed inclusion body
formation due to stress (data not shown) when grown at
37°C. The pH was automatically maintained at 7.0 using
10% orthophosphoric acid and 2 M sodium hydroxide as
correction solutions. The process was monitored by a
ADAM-4060 relay output module (Advantech Ltd., USA)
and run by using DASYLAB 6.0 software (National Instru-
ments Service GmbH, Germany).Continuous cultivation
The chemostat process was started as a batch fermenta-
tion, and upon reaching the end of exponential phase,
the feed and outlet pumps were switched on. The
desired space velocity (dilution rate) was set by the flow
rate of the medium. The feed medium supplied from aTable 5 Composition of the HSG medium
Medium component Medium concentration/g L−1
Soy peptone 13.5
Yeast extract 7
Glycerol 14.9
NaCl 2.5
K2HPO4 2.3
KH2PO4 1.5
MgSO4 · H20 0.1440 L reservoir had the same composition as the medium
for batch but with 20 g L−1 glycerol. The culture volume
in the reactor was maintained at a constant level by op-
erating the inlet pump at the exact flow rate required
whereas the outlet pump was operated at twice the flow
rate, with the suction pipe entrance positioned at a fixed
depth corresponding to a liquid working volume of 1 L.
Stably maintained levels of dissolved oxygen (DO) in the
reactor medium, CO2 content in the exit air and optical
density of the culture indicated a steady state. Any
change in the feed flow rate was followed by allowing
the system to stabilize by passing at least three to four
culture volumes through the reactor before a new steady
state was assumed.Measurement of growth
Prior to each cultivation experiment a single colony was
transferred from an agar plate into the appropriate
medium and cultivated overnight. The pre-culture media
were exactly the same as the media used in the subse-
quent cultivation experiments.
For the main cultivation the initial optical density at a
wavelength of 600 nm (OD600) was adjusted to 0.1. Over
the cultivation process samples were taken and the
optical density was measured against the cultivation
medium. If required, samples were diluted with fresh
cultivation medium.Determination of the specific growth rate
The specific growth rate (μ) was determined by means
of the standard method [25].
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The plasmid stability was determined by plating out
appropriately diluted samples on normal LB agar plates
prepared without antibiotics and incubating at 37°C for
at least 15 h. The colonies were then transferred onto an
LB agar plate containing 200 mg L−1 ampicillin followed
by incubation at 37°C for at least 15 h. The ratio of the
number of colonies counted on plates prepared in the
presence of antibiotics to that observed in the absence
of antibiotics was interpreted as plasmid stability.
For measurements of the plasmid content in the sam-
ples, a fixed volume of culture broth (2 mL) was used for
plasmid isolation by the Wizard Plus SV DNA Purification
System (Promega, USA). The elution of the plasmid from
the column was carried out into a constant volume
(50 μL) of nuclease-free water (Promega, USA). The
plasmid DNA concentration was measured by means of
the Nanodrop spectrophotometer (Peqlab Biotechnologie
GmbH, Germany), and the value was normalised to the
optical density of the culture sample.
Determination of methylglyoxal concentration
Methylglyoxal was quantitatively determined according
to the method described by Cooper [26].
Determination of glycerol concentration
Culture samples were centrifuged to separate the cells.
Glycerol concentration in the supernatant was measured
by HPLC using a Nucleogel sugar 810H cation exchange
column (Macherey-Nagel GmbH, Germany).
Assay for β-Glucanase activity
The recombinant protein expression was analysed with
an activity test for endo-1,3-1,4-β-glucan-glucanohy-
drolases. Substrates used were either lichenan (Roth,
Germany) or barley β-glucan (Megazyme, Ireland) both
of which have very similar properties. The substrate
contains 70% β-1,4- and 30% β-1,3-bonds.
The substrate solution in 40 mM sodium acetate
buffer [27] was incubated with samples containing the
enzyme to be assayed for 20 min. The reducing groups
released were analysed by the method based on dinitro-
salicylic acid by following the absorbance of light at a
wavelength of 530 nm (OD530). This was compared to
the maximum value expected for the particular substrate
at complete conversion, which can be obtained practic-
ally by applying an excess enzyme activity and incubat-
ing for 2 h. The final enzyme activity was obtained as a
volumetric activity taking into account the particular
enzyme kinetics [27]. One unit is defined as the enzyme
activity that releases an equivalent amount of 1 μmol
glucose residues per min at a temperature of 50°C
and a pH 5.6.Cloning
All cloning experiments were carried out according to
standard methods [28].
Sequencing
Potential clones were verified by sequencing the cloned
region using corresponding sequencing primers. Cycle-
sequencing was performed at the Centre for Biotechnol-
ogy (CeBiTec) (Bielefeld University, Germany). A BigDye®
terminator version 3.1 chemistry was used for the PCR in
a GeneAmp® PCR System 9700 (both Applied Biosystems,
Germany). The fragments of various lengths were then
separated by capillary electrophoresis and the fluorescence
signal of each base converted to their corresponding
digital data by a 96-well 3730xl DNA Analyzer (Applied
Biosystems, Germany).
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